in a double-blind , 12-week study of corticosteroid-dependent reversible bronchial asthma , 20 of 31 ( 64.5 % ) patients receiving triamcinolone acetonide aerosol , 800 microgram daily , were able to discontinue oral steroid therapy .
C0004096
bronchial asthma
C0040866
triamcinolone acetonide